Aclarion (ACON) Short term Debt (2023 - 2026)

Aclarion (ACON) reported Short term Debt of $45.0 for Q1 2026, down 28.57% quarter-over-quarter from $63.0 in Q4 2025.

Aclarion (ACON) Short term Debt (2023 - 2026) Analysis & Trends

Aclarion has reported Short term Debt for 4 years, with the latest figure at $45.0 in Q1 2026.

  • For the quarter ending Q1 2026, Short term Debt changed N/A year-over-year to $45.0; the trailing twelve-month figure through Mar 2026 stood at $45.0 (changed N/A YoY), and the FY2025 full-year result was $63.0, down 99.47% from the prior year.
  • Short term Debt for Q1 2026 stood at $45.0, down from $63.0 in the prior quarter.
  • The five-year high for Short term Debt was $367436.0 in Q3 2023, with the low at $45.0 in Q1 2026.
  • Historically, Short term Debt has averaged $90590.4 across 4 years, with a median of $25797.5 in 2024.
  • Annual changes were most pronounced in 2024 — Short term Debt sank 89.21% — and 2025, when it sank 99.47%.
  • Aclarion's Short term Debt stood at $121326.0 in 2023, then plunged by 90.22% to $11869.0 in 2024, then slumped by 99.47% to $63.0 in 2025, then retreated by 28.57% to $45.0 in 2026.
  • The last three Short term Debt figures came in at $45.0 (Q1 2026), $63.0 (Q4 2025), and $11869.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn
10 Aclarion 6.68 Mn -12.07 Mn 3,750.00

Historic Data

Download Data
DateValue
Mar 31, 2026 45.00
Dec 31, 2025 63.00
Dec 31, 2024 11,869.00
Jun 30, 2024 18,601.00
Mar 31, 2024 32,994.00
Dec 31, 2023 121,326.00
Sep 30, 2023 367,436.00
Jun 30, 2023 172,389.00